Importance Pulmonary embolism (PE) is characterized by occlusion of blood flow in a
pulmonary artery, typically due to a thrombus that travels from a vein in a lower limb. The …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Right ventricular (RV) failure is a critical cause of morbidity and mortality in patients
presenting with pulmonary embolism (PE). The presentation of RV failure is based on the …

Background Right ventricular (RV) function plays a critical role in the pathophysiology and
acute prognosis of pulmonary embolism (PE). We analyzed the temporal changes of RV …

Great progress has been made in the recent years providing a wide range of therapeutic
options. Optimal selection of patients who could benefit from these treatments is the key and …

Intravenous therapy for patients with a range of haematological disorders is an essential
component of disease treatment. Although central venous access devices are preferred for …

Background Deaths from high‐risk pulmonary embolism (PE) appear to have increased in
the US over the last decade. Modifiable risks contributing to this worrisome trend present …

Introduction Availability of new treatment strategies for patients with acute pulmonary
embolism (PE) have changed clinical practice with potential influence in short-term patients' …

Venous thromboembolism (VTE) is the third most common cardiovascular disease. For most
patients, the standard of treatment has long consisted on low-molecular-weight heparin …

Pulmonary embolism can be acutely life-threatening and is associated with long-term
consequences such as recurrent venous thromboembolism and chronic thromboembolic …